Polyendocrine metabolic ovarian syndrome (PMOS), formerly known as polycystic ovary syndrome (PCOS), affects an estimated one in eight women worldwide and more than 170 million individuals during their reproductive years alone. The long-standing term “polycystic ovary syndrome” has increasingly been recognised as inaccurate and potentially harmful. It implies the presence of pathological ovarian cysts, which […]